Watchlists Portfolios Alerts Sign in Get started

Menu

Market-Moving News for February 19th

Benzinga Newsdesk Feb 19, 2025 1 year ago

MoversTrading Ideas

CMMB: 41% | Chemomab Therapeutics shares are trading higher after the company announced the completion of its end-of-phase 2 FDA meeting and alignment on a single Phase 3 registration study for Nebokitug. APPN:

CMMB: 41% | Chemomab Therapeutics shares are trading higher after the company announced the completion of its end-of-phase 2 FDA meeting and alignment on a single Phase 3 registration study for Nebokitug.

APPN: 10% | Appian shares are trading higher after the company reported better-than-expected Q4 EPS and revenue.

PERI: -17% | Perion Network shares are trading lower after the company missed Q4 revenue estimates.

Read the original